Literature DB >> 26661712

γ-Synuclein Expression Is a Malignant Index in Oral Squamous Cell Carcinoma.

J C Cheng1, M T Chiang2, C H Lee3, S Y Liu4, K C Chiu2, Y T Chou5, R Y Huang2, S M Huang6, Y S Shieh7.   

Abstract

Dysregulation of γ-synuclein (SNCG) has been reported in many cancers; however, its role in cancer development is still controversial. Here, we examined the potential involvement of DNA methylation in regulating SNCG and its role in oral squamous cell carcinoma (OSCC). We used 8 OSCC cell lines to investigate SNCG methylation and expression. SNCG methylation was examination by methylation-specific polymerase chain reaction and bisulfate sequencing. Cells showing a high degree of SNCG methylation were treated with 5-aza (methylation inhibitor), and changes in their methylation and expression profiles were analyzed. Functional effects of SNCG in OSCC were examined by its overexpression and knockdown. Additionally, methylation and expression of SNCG in OSCC tissues were investigated and correlated with clinicopathologic features. All OSCC cells showed detectable SNCG expression at the mRNA and protein levels. Methylation-specific polymerase chain reaction and bisulfate sequencing revealed high SNCG expression in SCC25 cells with the unmethylated allele, and their 15 CpG islands were unmethylated. The methylated allele was detected only in OEC-M1 cells exhibiting low SNCG expression, and their CpG islands were partially methylated. 5-aza treatment in OEC-M1 cells attenuated methylation and restored SNCG expression. SNCG overexpression increased colony forming, migration, and invasion abilities in OEC-M1 cells. Silencing SNCG in SCC25 cells suppressed these behaviors. All 25 tumor-adjacent normal tissues were negative for SNCG immunostaining. SNCG upregulation was frequently observed in dysplastic and OSCC tissues. Positive SNCG expression was found in 45% (37 of 82) OSCC tissues. Positive SNCG expression in OSCC significantly correlated with cancer staging and lymph node metastasis. However, SNCG methylation did not correlate with its expression and clinicopathologic variables in OSCC tissues. DNA methylation may participate in regulating SNCG expression in some OSCC cells. SNCG upregulation could be involved in OSCC progression. © International & American Associations for Dental Research 2015.

Entities:  

Keywords:  DNA methylation; epigenetics; gene expression; oral cancer; oral pathology; tumor progression

Mesh:

Substances:

Year:  2015        PMID: 26661712     DOI: 10.1177/0022034515621728

Source DB:  PubMed          Journal:  J Dent Res        ISSN: 0022-0345            Impact factor:   6.116


  5 in total

1.  Gamma synuclein is a novel nicotine responsive protein in oral cancer malignancy.

Authors:  Chia-Chen Hsu; Yu-Fu Su; Kuo-Yang Tsai; Feng-Chih Kuo; Chi-Fu Chiang; Chu-Yen Chien; Ying-Chen Chen; Chien-Hsing Lee; Yu-Chiao Wu; Kun Wang; Shyun-Yeu Liu; Yi-Shing Shieh
Journal:  Cancer Cell Int       Date:  2020-07-10       Impact factor: 5.722

2.  Alpha-synuclein contributes to malignant progression of human meningioma via the Akt/mTOR pathway.

Authors:  Yiqin Ge; Kan Xu
Journal:  Cancer Cell Int       Date:  2016-11-15       Impact factor: 5.722

3.  The anti-melanoma activity and oncogenic targets of hsa-miR-15a-5p.

Authors:  Christopher Alderman; Yixin Yang
Journal:  RNA Dis       Date:  2016-11-14

4.  SNCG promotes the progression and metastasis of high-grade serous ovarian cancer via targeting the PI3K/AKT signaling pathway.

Authors:  Jing Zhang; Xiao-Han Liu; Cong Li; Xiao-Xing Wu; Yan-Lin Chen; Wen-Wen Li; Xian Li; Fan Gong; Qin Tang; Dan Jiang
Journal:  J Exp Clin Cancer Res       Date:  2020-05-07

5.  Upregulation of Synuclein-γ and Snai1 Contributes to Poor Clinical Prognosis in Oral Squamous Cell Carcinoma Patients.

Authors:  Jie Yang; Yangyang Pan; Lu Peng; Licui Zhang; Juan Zhao; Zhihong Zheng; Jun Zheng; Xiaoli Xu; Yan Zeng
Journal:  Biomed Res Int       Date:  2022-04-07       Impact factor: 3.246

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.